Atypical severe central serous chorioretinopathy in a patient with systemic lupus erythematosus improved with a rapid reduction in glucocorticoid

作者：Sato Hiroe^*; Ito Satoshi; Nagai Shingo; Murasawa Akira; Wada Yoko; Murakami Shuichi; Kuroda Takeshi; Nakano Masaaki; Narita Ichiei

来源：Modern Rheumatology, 2013, 23(1): 172-174.

DOI：10.1007/s10165-012-0629-6

• Systemic lupus erythematosus
• Central serous chorioretinopathy
• Glucocorticoid
• Tacrolimus

A 36-year-old woman was diagnosed with systemic lupus erythematosus (SLE). Seven days after beginning glucocorticoid treatment, she developed reduced visual acuity, and atypical severe central serous chorioretinopathy (CSC) was confirmed. Since glucocorticoid use is an important risk factor for CSC, the PSL was reduced, tacrolimus was added, and the visual acuity improved rapidly. Reduction in glucocorticoid combined with the use of immunosuppressive agents is one option for preventing a deterioration in atypical severe CSC while still controlling SLE.

• 出版日期2013-1